Literature DB >> 34244978

A Response to: Letter to the Editor Regarding PRK Enhancement for Residual Refractive Error After Primary PRK: A Retrospective Study.

Majid Moshirfar1, Yasmyne Ronquillo2, Shannon McCabe2.   

Abstract

Entities:  

Year:  2021        PMID: 34244978      PMCID: PMC8319265          DOI: 10.1007/s40123-021-00371-0

Source DB:  PubMed          Journal:  Ophthalmol Ther


× No keyword cloud information.
Dear Drs. Benito-Llopis and Teus, We acknowledge that widening our literature search to include articles involving “LASEK” and “surface ablation” would have allowed us to strengthen our assertion that surface ablation enhancements following previous surface ablation procedures are safe and effective, as well stated in Drs. Benito-Llopis and Teu’s 2010 article on this topic [1]. However, our focus was comparing our results with PRK enhancement after PRK to the specific FDA criteria for safety and efficacy of PRK. Given that a systematic review of the literature concluded that the comparative effectiveness of LASEK versus PRK in treating low to moderate myopic eyes is uncertain [2], we felt it would not be appropriate to compare our results to other surface ablation procedures with different techniques. We do agree that all surface ablation procedures should be considered minimal modification of the same corneal refractive procedure, but since existing scientific literature has intentionally created a distinction between them, we consequently chose to focus our comparison on the traditional surgical form of PRK with complete epithelial debridement. Again, we thank the authors for their comments as well as their valuable contribution to the literature.
  2 in total

1.  Efficacy of surface ablation retreatments using mitomycin C.

Authors:  Laura de Benito-Llopis; Miguel A Teus
Journal:  Am J Ophthalmol       Date:  2010-06-08       Impact factor: 5.258

Review 2.  Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.

Authors:  Shi-Ming Li; Siyan Zhan; Si-Yuan Li; Xiao-Xia Peng; Jing Hu; Hua Andrew Law; Ning-Li Wang
Journal:  Cochrane Database Syst Rev       Date:  2016-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.